158 related articles for article (PubMed ID: 9106629)
61. The activity of MAO A and B in rat renal cells and tubules.
Guimarães JT; Soares-da-Silva P
Life Sci; 1998; 62(8):727-37. PubMed ID: 9489509
[TBL] [Abstract][Full Text] [Related]
62. Effect of imidazolines on Na+ transport and intracellular pH in renal proximal tubule cells.
Bidet M; Poujeol P; Parini A
Biochim Biophys Acta; 1990 May; 1024(1):173-8. PubMed ID: 2337612
[TBL] [Abstract][Full Text] [Related]
63. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
Cesura AM; Bös M; Galva MD; Imhof R; Da Prada M
Mol Pharmacol; 1990 Mar; 37(3):358-66. PubMed ID: 2314388
[TBL] [Abstract][Full Text] [Related]
64. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.
Saura J; Kettler R; Da Prada M; Richards JG
J Neurosci; 1992 May; 12(5):1977-99. PubMed ID: 1578281
[TBL] [Abstract][Full Text] [Related]
65. In vitro and ex vivo distribution of [3H]harmane, an endogenous beta-carboline, in rat brain.
Anderson NJ; Tyacke RJ; Husbands SM; Nutt DJ; Hudson AL; Robinson ES
Neuropharmacology; 2006 Mar; 50(3):269-76. PubMed ID: 16242163
[TBL] [Abstract][Full Text] [Related]
66. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain.
Olmos G; Alemany R; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1994 Apr; 111(4):997-1002. PubMed ID: 8032628
[TBL] [Abstract][Full Text] [Related]
67. Characterization of imidazoline-guanidinium receptive sites in renal medulla from human kidney.
Lachaud V; Limon I; Tesson F; Coupry I; Parini A
Am J Hypertens; 1992 Apr; 5(4 Pt 2):69S-71S. PubMed ID: 1350730
[TBL] [Abstract][Full Text] [Related]
68. Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I(2) sites.
MacInnes N; Handley SL
Eur J Pharmacol; 2001 Oct; 428(2):221-5. PubMed ID: 11675039
[TBL] [Abstract][Full Text] [Related]
69. [3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors.
MacKinnon AC; Redfern WS; Brown CM
Br J Pharmacol; 1995 Sep; 116(2):1729-36. PubMed ID: 8528552
[TBL] [Abstract][Full Text] [Related]
70. Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases.
Bianchi P; Séguélas MH; Parini A; Cambon C
J Am Soc Nephrol; 2003 Apr; 14(4):855-62. PubMed ID: 12660319
[TBL] [Abstract][Full Text] [Related]
71. Targeting imidazoline site on monoamine oxidase B through molecular docking simulations.
Moraes FP; de Azevedo WF
J Mol Model; 2012 Aug; 18(8):3877-86. PubMed ID: 22426510
[TBL] [Abstract][Full Text] [Related]
72. Densities of I2-imidazoline receptors, imidazoline receptor proteins, and MAO-B sites in human gliomas and pituitary adenomas.
Barturen F; Ventayol P; Ozaita A; Escribá PV; Meana JJ; García-Sevilla JA
Ann N Y Acad Sci; 1999 Jun; 881():203-7. PubMed ID: 10415917
[No Abstract] [Full Text] [Related]
73. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
Itzhak Y; Mash D; Zhang SH; Stein I
Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
[TBL] [Abstract][Full Text] [Related]
74. RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.
Brown CM; MacKinnon AC; Redfern WS; Williams A; Linton C; Stewart M; Clague RU; Clark R; Spedding M
Br J Pharmacol; 1995 Sep; 116(2):1737-44. PubMed ID: 8528553
[TBL] [Abstract][Full Text] [Related]
75. 4-Fluoro-3-nitrophenyl azide, a selective photoaffinity label for type B monoamine oxidase.
Chen S; Shih JC; Xu QP
Biochem Pharmacol; 1985 Mar; 34(6):781-8. PubMed ID: 3977955
[TBL] [Abstract][Full Text] [Related]
76. Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis.
Trouche E; Mias C; Seguelas MH; Ordener C; Cussac D; Parini A
Stem Cells Dev; 2010 Oct; 19(10):1571-8. PubMed ID: 20073575
[TBL] [Abstract][Full Text] [Related]
77. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites.
Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
Neuropharmacology; 2007 Feb; 52(2):395-404. PubMed ID: 17045310
[TBL] [Abstract][Full Text] [Related]
78. High expression of monoamine oxidases in human white adipose tissue: evidence for their involvement in noradrenaline clearance.
Pizzinat N; Marti L; Remaury A; Leger F; Langin D; Lafontan M; Carpéné C; Parini A
Biochem Pharmacol; 1999 Dec; 58(11):1735-42. PubMed ID: 10571247
[TBL] [Abstract][Full Text] [Related]
79. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
80. Unusual pattern of beta-phenylethylamine deamination in the rat heart.
Tiago Guimarães J; Soares-da-Silva P
Neurobiology (Bp); 2000; 8(1):109-18. PubMed ID: 11008882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
